Group One Trading’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,000
| Closed | -$15K | – | 9188 |
|
|
2021
Q3 | $15K | Buy |
+3,000
| New | +$14.6K | ﹤0.01% | 7331 |
|
|
2021
Q2 | – | Sell |
-600
| Closed | -$3K | – | 8791 |
|
|
2021
Q1 | $3K | Buy |
+600
| New | +$3.13K | ﹤0.01% | 7361 |
|
|
2020
Q1 | – | Sell |
-11,000
| Closed | -$42K | – | 5979 |
|
|
2019
Q4 | $42K | Buy |
11,000
+900
| +9% | +$4.31K | ﹤0.01% | 4088 |
|
|
2019
Q3 | $52K | Hold |
10,100
| – | – | ﹤0.01% | 3954 |
|
|
2019
Q2 | $63K | Buy |
10,100
+10,000
| +10,000% | +$57.5K | ﹤0.01% | 3651 |
|
|
2019
Q1 | $1K | Sell |
100
-20,400
| -100% | -$183K | ﹤0.01% | 4694 |
|
|
2018
Q4 | $175K | Sell |
20,500
-6,500
| -24% | -$84.5K | ﹤0.01% | 2789 |
|
|
2018
Q3 | $541K | Sell |
27,000
-3,300
| -11% | -$77.5K | ﹤0.01% | 2213 |
|
|
2018
Q2 | $783K | Sell |
30,300
-9,500
| -24% | -$263K | 0.01% | 1932 |
|
|
2018
Q1 | $951K | Buy |
39,800
+15,100
| +61% | +$476K | 0.01% | 1561 |
|
|
2017
Q4 | $837K | Sell |
24,700
-58,200
| -70% | -$1.63M | 0.01% | 1860 |
|
|
2017
Q3 | $1.75M | Buy |
82,900
+77,300
| +1,380% | +$1.42M | 0.02% | 1144 |
|
|
2017
Q2 | $98K | Buy |
5,600
+5,400
| +2,700% | +$89.3K | ﹤0.01% | 3122 |
|
|
2017
Q1 | $4K | Buy |
+200
| New | +$3.41K | ﹤0.01% | 4360 |
|
|
2016
Q4 | – | Sell |
-100
| Closed | -$2K | – | 4997 |
|
|
2016
Q3 | $2K | Buy |
+100
| New | +$1.52K | ﹤0.01% | 4396 |
|
|
2016
Q1 | – | Sell |
-1,500
| Closed | -$42K | – | 5129 |
|
|
2015
Q4 | $42K | Buy |
+1,500
| New | +$25.3K | ﹤0.01% | 3514 |
|
Group One Trading's ADMS Position: Q4 2021 in Review
Group One Trading sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 16,483 shares — an estimated $81K sold.
Group One Trading first reported a position in ADMS in Q4 2015 and held it in 13 quarters. The position peaked at $794K in Q3 2017. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Group One Trading reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 16,483 Adamas Pharmaceuticals shares in Q4 2021, an estimated $81K.
- Group One Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 13 quarters.
- Group One Trading's Adamas Pharmaceuticals position peaked at $794K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.